Take Control of Your Recovery with a Long-Acting Shot

Groups providers offer medication for opioid use disorder (MOUD) to support your recovery. We prescribe buprenorphine in both oral and injectable forms—including Suboxone, Sublocade, and Brixadi—based on what’s best for your needs.

 Yes—Groups is covered by most insurance plans, including MaineCare and Medicare. If you’re uninsured, we offer affordable self-pay options and may have grants available to help cover the cost of care.

We accept: MaineCare, Anthem, United Healthcare, Community Health Options, Aetna, Point32, TRICARE.  Please call us at (888) 858-1723 to talk about your options. Making treatment affordable for you is our priority.

Both! We offer in-person support at our local offices or online using the Groups app. Whatever works best for you and your needs.

You’ll meet with a licensed counselor or Recovery Consultant who will ask questions about your health history. This helps us make sure our program is right for you. This will most likely be done virtually.
‍
Next, you’ll meet with a physician (also virtually) to go over any medical issues that could impact treatment. If you’re right for our treatment, they'll prescribe the right dose of medication to prevent cravings. If Groups isn’t the right fit, we’ll refer you to other treatment options.

Yes. Members complete weekly urine screens as part of treatment. The results are confidential between you and your care team. Suboxone is a highly regulated medication. Many states require treatment to include drug screens.

Drug tests also provide valuable information about treatment progress. Groups doesn’t punish members for positive drug screens. Instead, we work with members to help them stay safe and prevent or reduce opioid use.

Suboxone (buprenorphine/naloxone) is indicated for the treatment of opioid dependence in adults. Suboxone should not be taken by individuals who have been shown to be hypersensitive to buprenorphine or naloxone as serious adverse reactions, including anaphylactic shock, have been reported. Taking Suboxone (buprenorphine/naloxone) with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants can cause breathing problems that can lead to coma and death.

Other side effects may include headaches, nausea, vomiting, constipation, insomnia, pain, increased sweating, sleepiness, dizziness, coordination problems, physical dependence or abuse, and liver problems. For more information about Suboxone (buprenorphine/naloxone) see Suboxone.com, the full Prescribing Information, and Medication Guide, or talk to your healthcare provider.

You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Prescription SUBLOCADE, with counseling and psychosocial support, is for adults with moderate to severe opioid addiction who have started treatment with a dose of oral buprenorphine or are being treated with buprenorphine.

What is the most important information I should know about SUBLOCADE?

Because of the serious risk of potential harm or death from self-injecting SUBLOCADE into a vein (intravenously), it is only available through a restricted program called the SUBLOCADE REMS Program.SUBLOCADE is not available in retail pharmacies.Your SUBLOCADE injection will only be given to you by a certified healthcare provider.SUBLOCADE contains a medicine called buprenorphine which is an opioid that can cause serious and life‑threatening breathing problems, especially if you take or use certain other medicines or drugs.Talk to your healthcare provider about naloxone, which is a medicine that is available to patients for emergency treatment of an opioid overdose. If naloxone is given, call 911 or get emergency medical help right away to treat overdose or accidental use of an opioid.SUBLOCADE may cause serious and life-threatening breathing problems. Get emergency help right away if you: feel faint, dizzy, confused, sleepy or uncoordinated, have blurred vision or slurred speech, are breathing slower than normal or cannot think well or clearly. Do not take SUBLOCADE with certain medicines. Taking SUBLOCADE with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.In an emergency, have family members tell emergency department staff that you are physically dependent on an opioid and are being treated with SUBLOCADE. You may have detectable levels of SUBLOCADE in your body for several months after stopping treatment with SUBLOCADE.Possible serious side effects include: trouble breathing, sleepiness, dizziness, problems with coordination, physical dependence or abuse, liver problems, allergic reaction, opioid withdrawal, and decrease in blood pressure. The most common side effects include:  constipation, headache, nausea, injection site itching, vomiting, increase in liver enzymes, tiredness, or injection site pain. These are not all the possible side effects. Call your healthcare provider for medical advice about side effects.

To report a pregnancy or side effects associated with taking SUBLOCADE or any safety‑related information, product complaint, request for medical information, or product query contact PatientSafetyNA@indivior.com or 1-877-782-6966. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.For more information about SUBLOCADE, see sublocade.com, the full Prescribing Information, including BOXED WARNING, and Medication Guide. For REMS information visit www.sublocadeREMS.com.

BRIXADI is a prescription medicine used to treat moderate to severe opioid addiction (dependence) to opioid drugs (prescription or illegal) in people:who have started treatment with a single dose of a buprenorphine medicine in the form of a sublingual tablet or buccal film (transmucosal), OR who are already being treated with buprenorphineBRIXADI should be used as part of a complete treatment plan that also includes counseling and behavioral therapy.IMPORTANT SAFETY INFORMATIONWhat is the most important information I should know about BRIXADI?Because of the serious risk of potential harm or death from self-injecting BRIXADI into a vein (intravenously), it is only available through a restricted program called the BRIXADI Risk Evaluation and Mitigation Strategy (REMS) Program.BRIXADI is not available in retail pharmacies.Your BRIXADI injection will only be given to you by a healthcare provider.BRIXADI (buprenorphine) extended-release injection for subcutaneous use contains a medicine called buprenorphine. Buprenorphine is an opioid that can cause serious and life-threatening breathing problems, especially if you take or use certain other medicines or drugs.Talk to your healthcare provider about naloxone. Naloxone is a medicine that is available to patients for the emergency treatment of an opioid overdose. If naloxone is given, you must call 911 or get emergency medical help right away to treat an overdose or accidental use of an opioid.BRIXADI can cause serious and life-threatening breathing problems. Get emergency help right away if you:  feel faint, feel dizzy, are confused, feel sleepy or uncoordinated, have blurred vision, have slurred speech, are breathing slower than normal, cannot think well or clearly.Do not take BRIXADI with certain medicines. Taking BRIXADI with other opioid medicines, benzodiazepines, alcohol, other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.In an emergency, have family members tell the emergency department staff that you are physically dependent on an opioid and are being treated with BRIXADI.You may have detectable levels of BRIXADI in your body for several months after stopping treatment with BRIXADI.BRIXADI can cause serious side effects, including:  trouble breaching, sleepiness, dizziness, problems with coordination, physical dependence or abuse, liver problems, allergic reaction, opioid withdrawal, or decrease in blood pressure. The most common side effects of BRIXADI include: injection site pain, headache, constipation, nausea, injection site redness, injection site itching, trouble sleeping (insomnia), and urinary tract infection. These are not all the possible side effects of BRIXADI. Call your healthcare provider for medical advice about side effects.   

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.For more information about BRIXADI, ask your healthcare provider or go to www.BRIXADI.com or call 1-833-274-9234.This information does not take the place of talking with your healthcare provider for medical advice about your condition or treatment.Please see BRIXADI Medication Guide and Full Prescribing Information, including BOXED WARNING.